Cambridge Investment Research Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Sell |
|
|||||
|
2025
Q1 | $14.5M | Buy |
|
|||||
|
2024
Q4 | $11.2M | Sell |
|
|||||
|
2024
Q3 | $16.3M | Sell |
|
|||||
|
2024
Q2 | $17.6M | Buy |
|
|||||
|
2024
Q1 | $14.5M | Buy |
|
|||||
|
2023
Q4 | $11.1M | Sell |
|
|||||
|
2023
Q3 | $10.6M | Buy |
|
|||||
|
2023
Q2 | $9.85M | Buy |
|
|||||
|
2023
Q1 | $7.33M | Sell |
|
|||||
|
2022
Q4 | $9.29M | Sell |
|
|||||
|
2022
Q3 | $9.02M | Buy |
|
|||||
|
2022
Q2 | $9.19M | Sell |
|
|||||
|
2022
Q1 | $9.47M | Buy |
|
|||||
|
2021
Q4 | $8.81M | Buy |
|
|||||
|
2021
Q3 | $6.52M | Sell |
|
|||||
|
2021
Q2 | $7.2M | Buy |
|
|||||
|
2021
Q1 | $6.44M | Sell |
|
|||||
|
2020
Q4 | $5.99M | Sell |
|
|||||
|
2020
Q3 | $6.65M | Buy |
|
|||||
|
2020
Q2 | $5.63M | Buy |
|
|||||
|
2020
Q1 | $4.69M | Sell |
|
|||||
|
2019
Q4 | $10.7M | Buy |
|
|||||
|
2019
Q3 | $7.46M | Buy |
|
|||||
|
2019
Q2 | $8.29M | Buy |
|
|||||
|
2019
Q1 | $7.21M | Buy |
|
|||||
|
2018
Q4 | $2.7M | Sell |
|
|||||
|
2018
Q3 | $2.85M | Sell |
|
|||||
|
2018
Q2 | $2.72M | Sell |
|
|||||
|
2018
Q1 | $2.66M | Sell |
|
|||||
|
2017
Q4 | $6.17M | Buy |
|
|||||
|
2017
Q3 | $5.19M | Buy |
|
|||||
|
2017
Q2 | $5.07M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $2.42M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.7M | Buy |
|
|||||
|
2015
Q4 | $1.56M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $774K | Buy |
|
|||||
|
2014
Q2 | $606K | Buy |
|
|||||
|
2014
Q1 | $516K | Sell |
|
|||||
|
2013
Q4 | $485K | Buy |
|
|||||
|
2013
Q3 | $378K | Buy |
|
|||||
|
2013
Q2 | $369K | Buy |
|